fashion -WSS

fashion

author：hotspot 2025-09-29 18:16:46 - browse：57

It’s no secret that biotech industry funding has fallen from its Covid highs. But with just a few months left in the year, it’s on track to hit lows that predate the pandemic.

New data from Pitchbook and the National Venture Capital Association show that both the number of deals and the amount of money that’s being invested in life science companies are down significantly. So far this year, there have been 1,384 VC deals struck in the field, the lowest figure since 2013. For comparison, there were roughly 2,122 financing deals made last year.

If dealmaking remains consistent for the rest of the year, it would put this year on par with the number of deals made in 2017.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： My daughter's legacy lives on through her writing, phage therapy

hotspot

WSS

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Group behind ProMed defends move to subscription

Moderna says combo Covid

Florida officials tell state schools to teach AP Psychology 'in its entirety'

CDC recommends RSV monoclonal antibody for infants

A controversial new treatment promises to make little people taller

hotspot

fashion

leisure time

Apple is now the first public company to be valued at $3 trillion

Late stage cancers on the rise after pandemic delayed screenings

ChatGPT in medicine: STAT answers readers' burning questions

Study links childhood stress with decline in older age

Affirmative action in medical school literally saved lives

The cancer stories no one wants to hear

At least 13 dead in Texas as scorching temps continue

Teladoc has a new CEO, but challenges remain the same

Alkermes shareholders re

5 takeaways from STAT's examination of Zynex Medical

explore

Medical device trials still don't enroll enough women, study finds

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Medicare slashes safety net hospital payments by nearly $1 billion

Alnylam reports growth in sales of rare disease treatments

Pharma companies must ensure equitable access to obesity drugs

Health care court cases: Humana, Sutter, Novant

knowledge

hotspot

hotspot

explore